The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Aciclovir (ACV), also known as acyclovir, is an antiviral medication. It is primarily used for the treatment of herpes simplex virus infections, chickenpox, and shingles. Other uses include prevention of cytomegalovirus infections following transplant and severe complications of Epstein-Barr virus infection.
The global Aciclovir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Aciclovir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Aciclovir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Aciclovir include Greater Pharma, LBS Labs, GlaxoSmithKline, Lex Ano, Salutas, Novartis, Teva, Stada Nordic and Cimed Industria de Medicamentos, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Aciclovir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aciclovir.
Report Scope
The Aciclovir market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Aciclovir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aciclovir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
- Greater Pharma
- LBS Labs
- GlaxoSmithKline
- Lex Ano
- Salutas
- Novartis
- Teva
- Stada Nordic
- Cimed Industria de Medicamentos
- Reman Drug
- L.E.T.I.
- Nichi-Iko Pharmaceutical
- Choseido Pharmaceutical
- Shiono Kemikaru
- Towa Yakuhin
- Wockhardt
- Takata Pharmaceutical
- Aliud
- Amneal Pharma
- Apotex
- Arrow
- Laboratoires Servier
- Sanofi
- Mylan
- Orion Pharma
- Pfizer
Segment by Type
- Generic
- Patent
Segment by Application
- Hospital
- Drug Store
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aciclovir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Aciclovir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Aciclovir Market Overview
1.1 Product Overview and Scope of Aciclovir
1.2 Aciclovir Segment by Type
1.2.1 Global Aciclovir Market Value Comparison by Type (2024-2030)
1.2.2 Generic
1.2.3 Patent
1.3 Aciclovir Segment by Application
1.3.1 Global Aciclovir Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Aciclovir Market Size Estimates and Forecasts
1.4.1 Global Aciclovir Revenue 2019-2030
1.4.2 Global Aciclovir Sales 2019-2030
1.4.3 Global Aciclovir Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Aciclovir Market Competition by Manufacturers
2.1 Global Aciclovir Sales Market Share by Manufacturers (2019-2024)
2.2 Global Aciclovir Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Aciclovir Average Price by Manufacturers (2019-2024)
2.4 Global Aciclovir Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Aciclovir, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aciclovir, Product Type & Application
2.7 Aciclovir Market Competitive Situation and Trends
2.7.1 Aciclovir Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Aciclovir Players Market Share by Revenue
2.7.3 Global Aciclovir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Aciclovir Retrospective Market Scenario by Region
3.1 Global Aciclovir Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Aciclovir Global Aciclovir Sales by Region: 2019-2030
3.2.1 Global Aciclovir Sales by Region: 2019-2024
3.2.2 Global Aciclovir Sales by Region: 2025-2030
3.3 Global Aciclovir Global Aciclovir Revenue by Region: 2019-2030
3.3.1 Global Aciclovir Revenue by Region: 2019-2024
3.3.2 Global Aciclovir Revenue by Region: 2025-2030
3.4 North America Aciclovir Market Facts & Figures by Country
3.4.1 North America Aciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Aciclovir Sales by Country (2019-2030)
3.4.3 North America Aciclovir Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Aciclovir Market Facts & Figures by Country
3.5.1 Europe Aciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Aciclovir Sales by Country (2019-2030)
3.5.3 Europe Aciclovir Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aciclovir Market Facts & Figures by Country
3.6.1 Asia Pacific Aciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Aciclovir Sales by Country (2019-2030)
3.6.3 Asia Pacific Aciclovir Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Aciclovir Market Facts & Figures by Country
3.7.1 Latin America Aciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Aciclovir Sales by Country (2019-2030)
3.7.3 Latin America Aciclovir Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Aciclovir Market Facts & Figures by Country
3.8.1 Middle East and Africa Aciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Aciclovir Sales by Country (2019-2030)
3.8.3 Middle East and Africa Aciclovir Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Aciclovir Sales by Type (2019-2030)
4.1.1 Global Aciclovir Sales by Type (2019-2024)
4.1.2 Global Aciclovir Sales by Type (2025-2030)
4.1.3 Global Aciclovir Sales Market Share by Type (2019-2030)
4.2 Global Aciclovir Revenue by Type (2019-2030)
4.2.1 Global Aciclovir Revenue by Type (2019-2024)
4.2.2 Global Aciclovir Revenue by Type (2025-2030)
4.2.3 Global Aciclovir Revenue Market Share by Type (2019-2030)
4.3 Global Aciclovir Price by Type (2019-2030)
5 Segment by Application
5.1 Global Aciclovir Sales by Application (2019-2030)
5.1.1 Global Aciclovir Sales by Application (2019-2024)
5.1.2 Global Aciclovir Sales by Application (2025-2030)
5.1.3 Global Aciclovir Sales Market Share by Application (2019-2030)
5.2 Global Aciclovir Revenue by Application (2019-2030)
5.2.1 Global Aciclovir Revenue by Application (2019-2024)
5.2.2 Global Aciclovir Revenue by Application (2025-2030)
5.2.3 Global Aciclovir Revenue Market Share by Application (2019-2030)
5.3 Global Aciclovir Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Greater Pharma
6.1.1 Greater Pharma Corporation Information
6.1.2 Greater Pharma Description and Business Overview
6.1.3 Greater Pharma Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Greater Pharma Aciclovir Product Portfolio
6.1.5 Greater Pharma Recent Developments/Updates
6.2 LBS Labs
6.2.1 LBS Labs Corporation Information
6.2.2 LBS Labs Description and Business Overview
6.2.3 LBS Labs Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.2.4 LBS Labs Aciclovir Product Portfolio
6.2.5 LBS Labs Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Corporation Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GlaxoSmithKline Aciclovir Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Lex Ano
6.4.1 Lex Ano Corporation Information
6.4.2 Lex Ano Description and Business Overview
6.4.3 Lex Ano Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lex Ano Aciclovir Product Portfolio
6.4.5 Lex Ano Recent Developments/Updates
6.5 Salutas
6.5.1 Salutas Corporation Information
6.5.2 Salutas Description and Business Overview
6.5.3 Salutas Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Salutas Aciclovir Product Portfolio
6.5.5 Salutas Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novartis Aciclovir Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Aciclovir Product Portfolio
6.7.5 Teva Recent Developments/Updates
6.8 Stada Nordic
6.8.1 Stada Nordic Corporation Information
6.8.2 Stada Nordic Description and Business Overview
6.8.3 Stada Nordic Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Stada Nordic Aciclovir Product Portfolio
6.8.5 Stada Nordic Recent Developments/Updates
6.9 Cimed Industria de Medicamentos
6.9.1 Cimed Industria de Medicamentos Corporation Information
6.9.2 Cimed Industria de Medicamentos Description and Business Overview
6.9.3 Cimed Industria de Medicamentos Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cimed Industria de Medicamentos Aciclovir Product Portfolio
6.9.5 Cimed Industria de Medicamentos Recent Developments/Updates
6.10 Reman Drug
6.10.1 Reman Drug Corporation Information
6.10.2 Reman Drug Description and Business Overview
6.10.3 Reman Drug Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Reman Drug Aciclovir Product Portfolio
6.10.5 Reman Drug Recent Developments/Updates
6.11 L.E.T.I.
6.11.1 L.E.T.I. Corporation Information
6.11.2 L.E.T.I. Aciclovir Description and Business Overview
6.11.3 L.E.T.I. Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.11.4 L.E.T.I. Aciclovir Product Portfolio
6.11.5 L.E.T.I. Recent Developments/Updates
6.12 Nichi-Iko Pharmaceutical
6.12.1 Nichi-Iko Pharmaceutical Corporation Information
6.12.2 Nichi-Iko Pharmaceutical Aciclovir Description and Business Overview
6.12.3 Nichi-Iko Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Nichi-Iko Pharmaceutical Aciclovir Product Portfolio
6.12.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
6.13 Choseido Pharmaceutical
6.13.1 Choseido Pharmaceutical Corporation Information
6.13.2 Choseido Pharmaceutical Aciclovir Description and Business Overview
6.13.3 Choseido Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Choseido Pharmaceutical Aciclovir Product Portfolio
6.13.5 Choseido Pharmaceutical Recent Developments/Updates
6.14 Shiono Kemikaru
6.14.1 Shiono Kemikaru Corporation Information
6.14.2 Shiono Kemikaru Aciclovir Description and Business Overview
6.14.3 Shiono Kemikaru Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Shiono Kemikaru Aciclovir Product Portfolio
6.14.5 Shiono Kemikaru Recent Developments/Updates
6.15 Towa Yakuhin
6.15.1 Towa Yakuhin Corporation Information
6.15.2 Towa Yakuhin Aciclovir Description and Business Overview
6.15.3 Towa Yakuhin Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Towa Yakuhin Aciclovir Product Portfolio
6.15.5 Towa Yakuhin Recent Developments/Updates
6.16 Wockhardt
6.16.1 Wockhardt Corporation Information
6.16.2 Wockhardt Aciclovir Description and Business Overview
6.16.3 Wockhardt Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Wockhardt Aciclovir Product Portfolio
6.16.5 Wockhardt Recent Developments/Updates
6.17 Takata Pharmaceutical
6.17.1 Takata Pharmaceutical Corporation Information
6.17.2 Takata Pharmaceutical Aciclovir Description and Business Overview
6.17.3 Takata Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Takata Pharmaceutical Aciclovir Product Portfolio
6.17.5 Takata Pharmaceutical Recent Developments/Updates
6.18 Aliud
6.18.1 Aliud Corporation Information
6.18.2 Aliud Aciclovir Description and Business Overview
6.18.3 Aliud Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Aliud Aciclovir Product Portfolio
6.18.5 Aliud Recent Developments/Updates
6.19 Amneal Pharma
6.19.1 Amneal Pharma Corporation Information
6.19.2 Amneal Pharma Aciclovir Description and Business Overview
6.19.3 Amneal Pharma Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Amneal Pharma Aciclovir Product Portfolio
6.19.5 Amneal Pharma Recent Developments/Updates
6.20 Apotex
6.20.1 Apotex Corporation Information
6.20.2 Apotex Aciclovir Description and Business Overview
6.20.3 Apotex Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Apotex Aciclovir Product Portfolio
6.20.5 Apotex Recent Developments/Updates
6.21 Arrow
6.21.1 Arrow Corporation Information
6.21.2 Arrow Aciclovir Description and Business Overview
6.21.3 Arrow Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Arrow Aciclovir Product Portfolio
6.21.5 Arrow Recent Developments/Updates
6.22 Laboratoires Servier
6.22.1 Laboratoires Servier Corporation Information
6.22.2 Laboratoires Servier Aciclovir Description and Business Overview
6.22.3 Laboratoires Servier Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Laboratoires Servier Aciclovir Product Portfolio
6.22.5 Laboratoires Servier Recent Developments/Updates
6.23 Sanofi
6.23.1 Sanofi Corporation Information
6.23.2 Sanofi Aciclovir Description and Business Overview
6.23.3 Sanofi Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Sanofi Aciclovir Product Portfolio
6.23.5 Sanofi Recent Developments/Updates
6.24 Mylan
6.24.1 Mylan Corporation Information
6.24.2 Mylan Aciclovir Description and Business Overview
6.24.3 Mylan Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Mylan Aciclovir Product Portfolio
6.24.5 Mylan Recent Developments/Updates
6.25 Orion Pharma
6.25.1 Orion Pharma Corporation Information
6.25.2 Orion Pharma Aciclovir Description and Business Overview
6.25.3 Orion Pharma Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Orion Pharma Aciclovir Product Portfolio
6.25.5 Orion Pharma Recent Developments/Updates
6.26 Pfizer
6.26.1 Pfizer Corporation Information
6.26.2 Pfizer Aciclovir Description and Business Overview
6.26.3 Pfizer Aciclovir Sales, Revenue and Gross Margin (2019-2024)
6.26.4 Pfizer Aciclovir Product Portfolio
6.26.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aciclovir Industry Chain Analysis
7.2 Aciclovir Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aciclovir Production Mode & Process
7.4 Aciclovir Sales and Marketing
7.4.1 Aciclovir Sales Channels
7.4.2 Aciclovir Distributors
7.5 Aciclovir Customers
8 Aciclovir Market Dynamics
8.1 Aciclovir Industry Trends
8.2 Aciclovir Market Drivers
8.3 Aciclovir Market Challenges
8.4 Aciclovir Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
